<p>(A) Detection of apoptosis by TUNEL assay. Photomicrographs of HepG2 cells treated for 24 h with the indicated concentrations of CLX and SOR either alone or in combination. Apoptotic cells were visualized by TUNEL staining as described in the Materials and Methods section. (B) Quantitative analysis of TUNEL-positive HepG2 and Huh7 cells. Data are expressed as the means ± SD of two separate experiments. *<i>p</i><0.05, versus each agent alone. (C) Cell proliferation was assessed by BrdU assay. Cells were treated for 48 h with the indicated concentrations of CLX and SOR either alone or in combination. Data are expressed as the percentage of the control cells and are the means ± SD of three separate experiments. *<i>p</i><0.05; **<i>p</i><0...
<p>(A) HepG2 cells were pretreated with 3 µmol/L tunicamycin for 8 hr, either in the absence or the ...
<p>(A) The representative apoptosis in BEL-7402 cells (n = 3) induced by HBO, sorafenib, cisplatin a...
<p>(A) After pretreatment with 10 µM Stattic or DMSO for 20 min, HaCaT cells were incubated in mediu...
<p>Cell growth of HepG2 and Huh7 cells was determined by clonogenic assay after treatment with CLX a...
<p>Cells were treated for 48 h with the indicated concentrations of CLX and SOR and their combinatio...
<p>(A) Cells were treated with various concentrations of celecoxib for 24 h. Cell viability was asse...
Molecular targeted therapy has shown promise as a treatment for advanced hepatocellular carcinoma (H...
Molecular targeted therapy has shown promise as a treatment for advanced hepatocellular carcinoma (H...
AIM: To investigate the combined chemotherapeutic effects of celecoxib when used with 5-FU in vitro....
<p>CGCCA cells were treated with the indicated concentrations of celecoxib for 2 days. (A) TUNNEL as...
<p>CDI of the combination of sorafenib and celecoxib in HepG2 and Huh7 cells.</p
<p>Following incubation with increasing doses of sorafenib, viable cell counts and apoptotic cell de...
<p>(A) Cells were transfected with GRP78 siRNA (10 nM) or scramble siRNA (10 nM) (as a control); the...
<p>(A-D) HCC cells were pre-treated with 25 µM chrysin for 1 h, followed by sorafenib treatment. Cel...
<p>(A) CGCCA cells with strong positive cytoplasmic immunoreactivity for COX-2 (400X). (B) Concentra...
<p>(A) HepG2 cells were pretreated with 3 µmol/L tunicamycin for 8 hr, either in the absence or the ...
<p>(A) The representative apoptosis in BEL-7402 cells (n = 3) induced by HBO, sorafenib, cisplatin a...
<p>(A) After pretreatment with 10 µM Stattic or DMSO for 20 min, HaCaT cells were incubated in mediu...
<p>Cell growth of HepG2 and Huh7 cells was determined by clonogenic assay after treatment with CLX a...
<p>Cells were treated for 48 h with the indicated concentrations of CLX and SOR and their combinatio...
<p>(A) Cells were treated with various concentrations of celecoxib for 24 h. Cell viability was asse...
Molecular targeted therapy has shown promise as a treatment for advanced hepatocellular carcinoma (H...
Molecular targeted therapy has shown promise as a treatment for advanced hepatocellular carcinoma (H...
AIM: To investigate the combined chemotherapeutic effects of celecoxib when used with 5-FU in vitro....
<p>CGCCA cells were treated with the indicated concentrations of celecoxib for 2 days. (A) TUNNEL as...
<p>CDI of the combination of sorafenib and celecoxib in HepG2 and Huh7 cells.</p
<p>Following incubation with increasing doses of sorafenib, viable cell counts and apoptotic cell de...
<p>(A) Cells were transfected with GRP78 siRNA (10 nM) or scramble siRNA (10 nM) (as a control); the...
<p>(A-D) HCC cells were pre-treated with 25 µM chrysin for 1 h, followed by sorafenib treatment. Cel...
<p>(A) CGCCA cells with strong positive cytoplasmic immunoreactivity for COX-2 (400X). (B) Concentra...
<p>(A) HepG2 cells were pretreated with 3 µmol/L tunicamycin for 8 hr, either in the absence or the ...
<p>(A) The representative apoptosis in BEL-7402 cells (n = 3) induced by HBO, sorafenib, cisplatin a...
<p>(A) After pretreatment with 10 µM Stattic or DMSO for 20 min, HaCaT cells were incubated in mediu...